Document Details
Form
Filing Date
Feb 16, 2021
Document Date
Mar 12, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.